Pulmonary arterial hypertension, a disease that leads to worsening lung and heart problems that eventually become life-threatening, is treated with drugs that alleviate symptoms. FDA approval of a new ...

Please provide your email address to receive an email when new articles are posted on . Lifetime risk for hypertension is up to 90% among U.S. adults. Updated guidelines and a pipeline of novel drugs ...

Weight-loss medications and surgical procedures show promise for reducing the long-term effects of high blood pressure (also called hypertension) in people who are overweight or have obesity, ...

The retrospective study found patients on Bruton’s tyrosine kinase inhibitors are similar to the general population in the sense that it usually takes at least 2 anti-hypertensive drugs to control ...

Different people respond better to different drugs for hypertension, meaning that personalizing treatment options may improve treatment efficacy. The corresponding study was published in JAMA.

The information is based on latest research by Uppsala University involving 340,000 patients, published in EClinicalMedicine. The study establishes that ARB medications effectively curtail blood ...